Imiquimod and Influenza Vaccine for Immunocompromised Patients
Clinical trial NCT02960815 · COMPLETED
Trial details
- NCT number
- NCT02960815
- Sponsor
- University of Lausanne Hospitals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-06-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.